Who Is Buying IBM? Hedge Fund Activity in 2026

International Business Machines — the company that invented the mainframe, survived the PC revolution, and pivoted through the cloud era — has found new relevance in 2026 through enterprise AI. IBM's WatsonX platform, Red Hat's hybrid cloud dominance, and a renewed focus on consulting and infrastructure have turned Big Blue into an unexpected AI beneficiary.

With $62 billion in institutional value and a 2:1 buy-to-sell ratio among tracked funds, IBM's 13F data shows steadily growing institutional conviction. Here's who's accumulating and who's stepping back.

IBM Institutional Snapshot

The 6-to-3 buy-sell ratio is solidly bullish, while the 7 holding funds create a stable institutional foundation. IBM's combination of dividend yield, AI exposure, and defensive characteristics makes it attractive across multiple investment styles.

Who's Buying IBM in 2026?

Vanguard Group — $24.1B (Increased)

Vanguard's $24.1 billion IBM position makes it the largest institutional holder by a wide margin. The increase reflects both index-driven flows and active manager conviction within Vanguard's fund complex. IBM's growing weight in technology indices drives mechanical buying that supports the stock.

State Street Global Advisors — $13.6B (Increased)

State Street boosted its IBM holding to $13.6 billion. Together with Vanguard, the two passive giants hold nearly $38 billion in IBM — representing over 60% of the tracked institutional value. Their increases provide a solid floor for the stock.

Citadel Advisors (Ken Griffin) — $63M (Increased)

Citadel increased its IBM position to $63 million. While modest relative to Citadel's portfolio, the increase suggests Griffin's teams see favorable risk-reward in IBM's valuation and AI narrative.

D.E. Shaw — $60.8M (Increased)

D.E. Shaw boosted its IBM exposure to $60.8 million. The quant fund's algorithms are detecting positive signals in IBM's fundamentals, likely driven by accelerating consulting revenue tied to enterprise AI implementations.

Baker Bros Advisors — $23.1M (Increased)

Baker Bros added to its IBM position, now at $23.1 million. The diversified fund sees value in IBM's steady cash flows and dividend profile.

Who's Selling IBM?

Appaloosa Management (David Tepper) — $212.6M (Decreased)

Appaloosa trimmed its IBM position to $212.6 million but remains a significant holder. Tepper may be reallocating toward higher-growth opportunities while maintaining core exposure to IBM's dividend and AI story.

Millennium Management (Israel Englander) — $70.1M (Decreased)

Millennium reduced its IBM stake to $70.1 million. The multi-strategy fund's pod managers may have found more compelling alpha opportunities elsewhere in the technology sector.

Canyon Capital — $5.5M (Decreased)

Canyon made a small reduction to $5.5 million, a minimal holding that suggests IBM is a peripheral position for the fund.

Notable Moves

Third Point (Dan Loeb) — NEW Position ($186.1K)

The most intriguing move is Third Point opening a new position in IBM, albeit a small $186.1K starter stake. Dan Loeb's activist-oriented fund doesn't typically take positions without a thesis. While the position size is modest, it could represent an initial exploration of IBM as an activist or event-driven opportunity. Third Point often starts small and scales up if their thesis develops. This is a position worth monitoring in future quarters.

The Holding Majority

With 7 out of 16 funds holding steady, IBM has the highest hold ratio of any stock in this batch. This suggests a stable ownership base — funds that own IBM are comfortable maintaining their positions rather than trading around them. For a dividend-paying stock with defensive characteristics, this stability is exactly what long-term investors want to see. The holding funds include some of the most prominent names in institutional investing, reinforcing IBM's role as a core portfolio allocation rather than a tactical trade.

Minimal Hedge Fund Selling Pressure

Only 3 funds are selling, and even among sellers, the positions remain substantial ($212.6M for Appaloosa, $70.1M for Millennium). This isn't a rush for the exits — it's measured profit-taking from funds that still believe in the IBM story enough to maintain meaningful exposure.

What This Signals

IBM's institutional flow data points to quiet, steady accumulation rather than speculative fervor. The 6-to-3 buy-sell ratio combined with 7 holding funds creates a pattern of institutional confidence that doesn't make headlines but steadily supports the stock.

The bull case rests on IBM's successful positioning at the intersection of enterprise AI and hybrid cloud. WatsonX is gaining enterprise customers, Red Hat continues to dominate Kubernetes and hybrid infrastructure, and IBM's consulting arm is benefiting from companies seeking help implementing AI solutions. At ~$248 per share with a healthy dividend yield, IBM offers a rare combination of AI upside and income. The company has raised its dividend for over 25 consecutive years, making it an attractive holding for income-focused institutional investors and pension funds.

IBM's pivot under CEO Arvind Krishna has been deliberate — shedding Kyndryl (the managed infrastructure business) allowed IBM to focus on higher-margin software and consulting. The strategy is working: recurring revenue now represents a growing share of the top line, and the Red Hat acquisition continues to pay dividends through cross-selling into IBM's massive enterprise client base.

Third Point's new position, while tiny, adds an element of intrigue. Loeb's fund specializes in identifying undervalued companies where strategic changes can unlock value. If Third Point scales its IBM position in coming quarters, it could signal a more activist-driven catalyst on the horizon.

The selling from Appaloosa, Millennium, and Canyon is modest and doesn't suggest fundamental concerns. All three maintained their positions rather than exiting completely, indicating the sells are tactical rather than conviction-driven.

For investors seeking AI exposure with defensive characteristics, IBM's institutional data provides reassurance. The smart money is quietly accumulating, long-term holders are staying put, and even the sellers aren't leaving. That's a bullish foundation.

Track IBM Institutional Activity

Track IBM institutional moves in real-time with Freenance Smart Money — we track 35 funds with $21.4T total AUM across 77,111 positions. See who's buying and selling at app.freenance.io/smart-money/ticker/IBM.

Related Articles

• Who Is Buying NVIDIA? Hedge Fund Activity in 2026
• Who Is Buying Apple? Hedge Fund Activity in 2026
• Who Is Buying Tesla? Hedge Fund Activity in 2026

FAQ

Which hedge funds are accumulating IBM shares?

13F filings show six tracked funds increased IBM positions, including Vanguard ($24.1B), State Street ($13.6B), Citadel, D.E. Shaw and Baker Bros Advisors. Third Point also opened a small new position, which is notable given Dan Loeb's history of starting modest before scaling activist or event-driven theses.

How do Red Hat and hybrid cloud fit into IBM's institutional story?

Red Hat anchors IBM's hybrid cloud strategy through OpenShift and Linux, generating recurring software revenue that institutional analysts view as more durable than legacy mainframe sales. 13F commentary often connects D.E. Shaw and Vanguard's continued accumulation to this software-mix shift.

What role does WatsonX play in the bull case on IBM?

WatsonX positions IBM as an enterprise-AI platform vendor focused on regulated industries that need governance, lineage and on-prem options. Institutional buyers see this as a differentiated AI angle versus hyperscalers, especially when combined with IBM Consulting helping clients deploy AI internally.

Why is IBM attractive to dividend-focused institutions?

IBM has raised its dividend for more than two decades and offers a high yield relative to other large-cap tech names. 13F data shows pension-aligned managers and income mandates anchoring the float, which helps explain the unusually high number of "holding" funds in the latest filings.

Is the IBM 13F data sufficient on its own to make a decision?

No. 13F reports are quarterly snapshots and don't show intra-quarter trades, options hedges or short positions. The page is informational only and IBM's AI and software-shift thesis should be evaluated alongside personal financial goals, risk tolerance and independent research.